Literature DB >> 10781955

Regional and cellular specificity of the expression of TPRD, the tetratricopeptide Down syndrome gene, during human embryonic development.

M Rachidi1, C Lopes, S Gassanova, P M Sinet, M Vekemans, T Attie, A L Delezoide, J M Delabar.   

Abstract

The TPRD gene (tetratricopeptide (TPR) containing Down syndrome gene) is one of the candidate genes in the Down syndrome chromosomal region-1. Duplication of this gene may be the cause of major phenotypic features of Down syndrome. Here we show that the TPRD expression is developmentally regulated during human embryogenesis. At the earliest stages of development (Carnegie 8-12) TPRD expression is ubiquitous. At later developmental stages (Carnegie stages 14, 16 and 18), it becomes restricted to the nervous system, as is the case for the mtprd gene during mouse development. We extended our analysis of TPRD expression during fetal development of the human nervous system (13, 22 and 24 weeks). A new oblique illumination technique was used to compare signal intensity and cell density. Some regions of the nervous system such as the external cortical layers of the brain, and the inner neuroblastic layer of the eye, strongly express the TPRD gene.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10781955     DOI: 10.1016/s0925-4773(00)00259-8

Source DB:  PubMed          Journal:  Mech Dev        ISSN: 0925-4773            Impact factor:   1.882


  5 in total

1.  Genome-wide gene expression profiling of human narcolepsy.

Authors:  Camilla Bernardini; Wanda Lattanzi; Paolo Bosco; Christian Franceschini; Giuseppe Plazzi; Fabrizio Michetti; Raffaele Ferri
Journal:  Gene Expr       Date:  2012

Review 2.  Developmental Neuropathology and Neurodegeneration of Down Syndrome: Current Knowledge in Humans.

Authors:  Zinnat Hasina; Nicole Wang; Chi Chiu Wang
Journal:  Front Cell Dev Biol       Date:  2022-05-23

3.  Overexpressed TTC3 Protein Tends to be Cleaved into Fragments and Form Aggregates in the Nucleus.

Authors:  Yueqing Gong; Kun Wang; Sheng-Ping Xiao; Panying Mi; Wanjie Li; Yu Shang; Fei Dou
Journal:  Neuromolecular Med       Date:  2018-09-10       Impact factor: 3.843

Review 4.  TTC3-Mediated Protein Quality Control, A Potential Mechanism for Cognitive Impairment.

Authors:  Xu Zhou; Xiongjin Chen; Tingting Hong; Miaoping Zhang; Yujie Cai; Lili Cui
Journal:  Cell Mol Neurobiol       Date:  2021-02-27       Impact factor: 4.231

5.  Tetratricopeptide repeat domain 3 overexpression tends to form aggregates and inhibit ubiquitination and degradation of DNA polymerase γ.

Authors:  Yueqing Gong; Xiaolan Wang; Xuan Shang; Sheng Ping Xiao; Wanjie Li; Yu Shang; Fei Dou
Journal:  Oncotarget       Date:  2017-11-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.